Dr. Ricardo Rendon did his medical school and residency in Bogota, Colombia. He subsequently completed a clinical and research UroOncology Fellowship at the University of Toronto, Canada and a Masters in Community Health Clinical Epidemiology. He joined Dalhousie University in Halifax, Canada in 2001 where he is a Professor in the Department of Urology and the Director of Research and Clinical Trials. He is the Chair of the Genito-Urinary Cancer Site Team, Nova Scotia Health Authority Cancer Program and a Senior Investigator at the Beatrice Hunter Cancer Research Institute. Dr. Rendon is currently the Vice-President of Education of the Canadian Urological Association. While his clinical practice focuses on all areas of urologic oncology, his research focuses on renal cell carcinoma, advanced prostate cancer and urothelial cell carcinoma. He has authored over 150 peer-reviewed manuscripts and has been particularly active in the development of clinical guidelines and national and international collaborations in kidney, bladder, upper tract urothelial cell carcinoma and prostate cancer.